BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 17344906)

  • 1. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
    Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
    Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery.
    Golzio M; Mazzolini L; Moller P; Rols MP; Teissié J
    Gene Ther; 2005 Feb; 12(3):246-51. PubMed ID: 15592423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical in vivo imaging of electrically mediated delivery of siRNA into muscle for gene function analysis.
    Golzio M; Teissié J
    Methods Mol Biol; 2008; 423():279-87. PubMed ID: 18370206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted gene silencing into solid tumors with electrically mediated siRNA delivery.
    Golzio M; Mazzolini L; Paganin-Gioanni A; Teissié J
    Methods Mol Biol; 2009; 555():15-27. PubMed ID: 19495685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence-specific gene silencing in murine muscle induced by electroporation-mediated transfer of short interfering RNA.
    Kishida T; Asada H; Gojo S; Ohashi S; Shin-Ya M; Yasutomi K; Terauchi R; Takahashi KA; Kubo T; Imanishi J; Mazda O
    J Gene Med; 2004 Jan; 6(1):105-10. PubMed ID: 14716682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
    Aigner A
    J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
    Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
    J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring RNA interference as a therapeutic strategy for renal disease.
    Takabatake Y; Isaka Y; Mizui M; Kawachi H; Shimizu F; Ito T; Hori M; Imai E
    Gene Ther; 2005 Jun; 12(12):965-73. PubMed ID: 15729369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells.
    Hoelters J; Ciccarella M; Drechsel M; Geissler C; Gülkan H; Böcker W; Schieker M; Jochum M; Neth P
    J Gene Med; 2005 Jun; 7(6):718-28. PubMed ID: 15712343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi.
    Xiao H; Wu Z; Shen H; Luo AL; Yang YF; Li XB; Zhu DY
    Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):342-8. PubMed ID: 18834355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
    Santel A; Aleku M; Keil O; Endruschat J; Esche V; Durieux B; Löffler K; Fechtner M; Röhl T; Fisch G; Dames S; Arnold W; Giese K; Klippel A; Kaufmann J
    Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases.
    Takahashi Y; Nishikawa M; Kobayashi N; Takakura Y
    J Control Release; 2005 Jul; 105(3):332-43. PubMed ID: 15936841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA.
    Inoue T; Sugimoto M; Sakurai T; Saito R; Futaki N; Hashimoto Y; Honma Y; Arai I; Nakaike S
    J Gene Med; 2007 Nov; 9(11):994-1001. PubMed ID: 17703497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted lipoplexes for siRNA delivery.
    Cardoso A; Trabulo S; Moreira JN; Düzgüneş N; de Lima MC
    Methods Enzymol; 2009; 465():267-87. PubMed ID: 19913172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of small interfering RNA by single-cell electroporation in cerebellar cell cultures.
    Tanaka M; Yanagawa Y; Hirashima N
    J Neurosci Methods; 2009 Mar; 178(1):80-6. PubMed ID: 19114056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.
    Schiffelers RM; Xu J; Storm G; Woodle MC; Scaria PV
    Arthritis Rheum; 2005 Apr; 52(4):1314-8. PubMed ID: 15818667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial delivery of siRNAs: a new approach to solid tumor therapy.
    Xu DQ; Zhang L; Kopecko DJ; Gao L; Shao Y; Guo B; Zhao L
    Methods Mol Biol; 2009; 487():161-87. PubMed ID: 19301647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.